Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

This study reports the initial experience at the University of California San Francisco (UCSF) with tumor resection and permanent, low-activity iodine 125 ((125)I) brachytherapy in patients with progressive or recurrent glioblastoma multiforme (GM) and compares these results to those of similar pati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Larson, David A., Suplica, Jeffrey M., Chang, Susan M., Lamborn, Kathleen R., McDermott, Michael W., Sneed, Penny K., Prados, Michael D., Wara, William M., Nicholas, M. Kelly, Berger, Mitchel S.
Formato: Artigo
Idioma:Inglês
Publicado: Duke University Press 2004
Assuntos:
Clinical Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871978/
https://ncbi.nlm.nih.gov/pubmed/15134626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000425
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares